These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16497499)

  • 1. Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
    Wang X; Xu F; Xu Q; Mahmud H; Houze J; Zhu L; Akerman M; Tonn G; Tang L; McMaster BE; Dairaghi DJ; Schall TJ; Collins TL; Medina JC
    Bioorg Med Chem Lett; 2006 May; 16(10):2800-3. PubMed ID: 16497499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of thiourea derivatives and carbonyl-2-aminothiazole derivatives for potential CCR4 antagonists using capillary zone electrophoresis.
    Zhang S; Qi H; Yakufu P; Zhao F; Ling X; Xiao J; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):75-82. PubMed ID: 21144808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of chemokine receptor CCR4 antagonist.
    Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
    Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3.
    Johnson M; Li AR; Liu J; Fu Z; Zhu L; Miao S; Wang X; Xu Q; Huang A; Marcus A; Xu F; Ebsworth K; Sablan E; Danao J; Kumer J; Dairaghi D; Lawrence C; Sullivan T; Tonn G; Schall T; Collins T; Medina J
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3339-43. PubMed ID: 17448658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydroquinoline derivatives as CRTH2 antagonists.
    Liu J; Wang Y; Sun Y; Marshall D; Miao S; Tonn G; Anders P; Tocker J; Tang HL; Medina J
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6840-4. PubMed ID: 19896843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4.
    Wang Y; Zhang Y; Han W; Li D; Tian L; Yin C; Ma D
    Int J Biochem Cell Biol; 2008; 40(5):909-19. PubMed ID: 18069042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17).
    Moroi Y; Yu B; Urabe K; Koga T; Nakahara T; Dainichi T; Uchi H; Furue M
    J Dermatol Sci; 2004 Dec; 36(3):186-8. PubMed ID: 15541643
    [No Abstract]   [Full Text] [Related]  

  • 15. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaryl substituted pyrazoles as potent CCR2 receptor antagonists.
    Pinkerton AB; Huang D; Cube RV; Hutchinson JH; Struthers M; Ayala JM; Vicario PP; Patel SR; Wisniewski T; DeMartino JA; Vernier JM
    Bioorg Med Chem Lett; 2007 Feb; 17(3):807-13. PubMed ID: 17088058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.
    Li AR; Johnson MG; Liu J; Chen X; Du X; Mihalic JT; Deignan J; Gustin DJ; Duquette J; Fu Z; Zhu L; Marcus AP; Bergeron P; McGee LR; Danao J; Lemon B; Carabeo T; Sullivan T; Ma J; Tang L; Tonn G; Collins TL; Medina JC
    Bioorg Med Chem Lett; 2008 Jan; 18(2):688-93. PubMed ID: 18061451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1).
    Karlström S; Nordvall G; Sohn D; Hettman A; Turek D; Åhlin K; Kers A; Claesson M; Slivo C; Lo-Alfredsson Y; Petersson C; Bessidskaia G; Svensson PH; Rein T; Jerning E; Malmberg Å; Ahlgen C; Ray C; Vares L; Ivanov V; Johansson R
    J Med Chem; 2013 Apr; 56(8):3177-90. PubMed ID: 23516963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
    Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
    Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.